Click on image to view larger version.

Figure 4 The effects of bradykinin (0.2, 0.6, and 2.0 µg/min) and papaverine (PA) (12 mg) on net tissue-type plasminogen activator (t-PA) release in the control group (solid circles), perindopril group (solid triangles), and losartan group (open squares). *p < 0.05 versus baseline.